Scott Purdon currently serves as the Head of Patient Advocacy at Myeloma UK since May 2023. Prior to this role, Scott co-founded and was the Managing Director of Kingdom Global Health Solutions, focusing on government affairs and market access from January 2021 to April 2023. Scott's extensive experience includes positions such as Head of Corporate Affairs Consultancy at Niche Science & Technology Ltd, and Senior Counsel and Director of Corporate Affairs at Cello Health Communications. Further notable roles include Head of Government Affairs and Public Policy UK and Ireland at Gilead Sciences, and Head of NHS Partnerships at the Association of the British Pharmaceutical Industry. Scott has a significant background in public policy and patient advocacy, notably during tenures at ViiV Healthcare and GSK, where strategic leadership was provided for various market access initiatives. Scott holds a Ph.D. in Molecular Biology and Genetics from the University of Aberdeen.
This person is not in any teams
Myeloma UK
Myeloma UK is the only organisation in the UK dealing exclusively with myeloma - our ultimate goal is to find a cure. We are dedicated to ensuring that patients get access to the right treatment at the right time, and to improving standards of treatment and care through research, education and awareness raising. Our organisation also provides a range of information and support services to patients, family and friends to help deal with a diagnosis of myeloma. Myeloma UK receives no Government funding and relies almost entirely on voluntary donations and fundraising.